Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Medartis Holding AG's share price for the quarter that ended in Dec. 2025 was $100. Medartis Holding AG's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 12.4 Mil. Therefore, Medartis Holding AG's market cap for the quarter that ended in Dec. 2025 was $1,243.3 Mil.
Medartis Holding AG's quarterly market cap
increased
from Dec. 2024 ($826.6 Mil) to Jun. 2025 ($828.0 Mil) and
increased
from Jun. 2025 ($828.0 Mil) to Dec. 2025 ($1,243.3 Mil).
Medartis Holding AG's annual market cap
declined
from Dec. 2023 ($963.5 Mil) to Dec. 2024 ($826.6 Mil) but then
increased
from Dec. 2024 ($826.6 Mil) to Dec. 2025 ($1,243.3 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Medartis Holding AG's Enterprise Value for Today is $1,427.6 Mil.
Medartis Holding AG (OTCPK:MDRSF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Medartis Holding AG Market Cap Related Terms
Medartis Holding AG Market Cap Historical Data
* Premium members only.
The historical data trend for Medartis Holding AG's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Medartis Holding AG's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medartis Holding AG Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medartis Holding AG's Market Cap distribution charts can be found below:
* The bar in red indicates where Medartis Holding AG's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Medartis Holding AG's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medartis Holding AG (MDRSF) has a Market Cap of $1,273.5 Mil as of Jul. 01, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Medartis Holding AG and its competitors. According to the industry distribution chart, Medartis Holding AG ranks #151 out of 868 companies in the Medical Devices & Instruments industry, placing it in the top 17.4%.
Is Medartis Holding AG's Market Cap too high?
Medartis Holding AG's current Market Cap is $1,273.5 Mil. The Medical Devices & Instruments industry median Market Cap is 118.46. Medartis Holding AG's value of $1,273.5 Mil is 975.1% above this industry median. Based on the distribution chart, Medartis Holding AG ranks #151 out of 868 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Medartis Holding AG has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does Medartis Holding AG's Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medartis Holding AG ranks #151 out of 868 companies for Market Cap. This places Medartis Holding AG in the top 17% of its industry — outperforming the majority of peers. The industry median Market Cap is 118.46. Medartis Holding AG's value of $1,273.5 Mil is 975.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 118.46, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medartis Holding AG's current Market Cap of $1,273.5 Mil is 975.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Medartis Holding AG and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 118.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medartis Holding AG's current Market Cap is $1,273.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medartis Holding AG stock overvalued right now?
Medartis Holding AG (MDRSF) has a current Market Cap of $1,273.5 Mil. The stock's GF Value™ is $151.13, compared to a current price of $115.00 — trading 23.9% below its estimated fair value. The current Market Cap is $1,273.5 Mil and 975.1% above the Medical Devices & Instruments industry median of 118.46. Medartis Holding AG's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Medartis Holding AG (MDRSF), the current Market Cap is $1,273.5 Mil as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medartis Holding AG (MDRSF) Overvalued in 2026?
Based on GuruFocus' analysis, Medartis Holding AG stock appears to be undervalued.
The current stock price of $115.00 is trading 23.9% below its estimated GF Value™ of $151.13.
Key valuation signals for MDRSF:
Market Cap: $1,273.5 Mil
GF Value™: $151.13 vs. price of $115.00 (23.9% below fair value)
Industry Position: 975.1% above the Medical Devices & Instruments median (#151 of 868)
No single metric tells the full story. See the MDRSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for the Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from Europe, Middle East and Africa (EMEA) and also has a presence in North America, Asia Pacific, and Latin America.
82GF Score
Get the complete analysis for MDRSF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MDRSF has been successfully added to your 
